Tuesday, August 01, 2023
Zuellig Pharma announced that it has entered into an agreement with, GSK, to establish their first vaccine distribution hub in the Singapore.
The partnership between Zuellig Pharma Singapore and GSK entails Zuellig Pharma providing GSK with warehousing and distribution services specifically tailored to cold-chain management for its vaccines.
The launch of GSK's regional vaccine distribution hub through its strategic partnership with Zuellig Pharma marks a significant milestone with far-reaching benefits.
This collaboration will have a profound and direct impact on vaccine availability in the region, along with several other positive outcomes by significantly decrease its supply chain's overall carbon emissions compared to traditional air transport methods.
The establishment of the new vaccine distribution hub in Singapore will serve as a pivotal vaccine supply gateway into the region. The vaccine distribution hub's adoption of a sea transport model will significantly reduce its supply chain carbon footprint by at least 30% compared to air transport.
